Unravelling the Anticancer Potential of Dietary Fibre

Dietary fibre is often championed for simple digestive health, but new research suggests its role may be far more sophisticated. A recent narrative review highlights the potential of fibre as both a preventive measure and an adjuvant therapy for colorectal carcinoma (CRC). According to the review, fibre acts through complex mechanisms, modulating cellular targets to hinder tumour survival, proliferation, and even angiogenesis—the process by which tumours grow new blood vessels.

Epidemiological evidence largely supports the view that diets rich in whole grains and fibre reduce CRC risk. Furthermore, preclinical studies using animal models and laboratory samples have shown that specific fibres, such as β-glucan, pectin, and resistant starch, exert direct anticancer effects. These bioactive compounds appear to disrupt the invasive behaviour of cancer cells.

Despite these promising biological insights, the translation to human treatment remains difficult. The review notes that clinical trials have produced inconclusive results, largely due to a lack of standardisation in dosages, fibre types, and study durations. To confirm fibre’s place in oncology, scientists are now calling for rigorous, prospectively planned randomised controlled trials.